Potential therapeutic target for hypertension identified
February 1st, 2009 - 12:09 pm ICT by ANIWashington, Feb 1 (ANI): Researchers from Louisiana State University have identified a potential therapeutic target for hypertension.
The team has discovered an enzyme known as Angiotensin-converting enzyme 2 (ACE2) in the brain that plays a critical role in the central regulation of blood pressure.
They showed that ACE2 helps preserve the function of a key spontaneous reflex involved in blood pressure regulation and confirms its potential as a target for the prevention or treatment of High Blood Pressure.
Beat-to-beat short-term regulation of blood pressure is provided by a spontaneous reflex called the baroreceptor reflex.
Receptors in the arteries sense blood pressure and relay the information to the central nervous system where a network of brain stem cells adjust vascular resistance and heart rate. Action of a hypertensive hormone Angiotensin II is known to interfere with that process.
During the study, the researchers demonstrated that chronically hypertensive mice showed dramatically decreased baroreceptor reflex sensitivity and ACE2 activity.
They found that by blocking action of A receptors AT1Rs, ACE2 activity increased.
“We now have evidence that brain ACE2 plays a critical role in baroreceptor reflex function and , consequently, in the prevention of hypertension,” says Dr. Xia.
For further analysis, the researchers generated a triple-transgenic mouse model with increased ACE2 on a background of chronic hypertension.
In this model, they observed that the impaired baroreceptor reflex and other critical functions normalized, as did blood pressure.
We now have evidence that brain ACE2 plays a critical role in baroreceptor reflex function and , consequently, in the prevention of hypertension,” says Dr. Xia.
“Beyond our discovery of ACE2, we have now confirmed its potential as a target for the treatment of hypertension and other cardiovascular diseases,” said co researcher Dr Eric Lazartigues, PhD, Assistant Professor of Pharmacology at LSU Health Sciences Center New Orleans.
The research is published in the issue of the peer reviewed journal, Hypertension. (ANI)
- Anti-hypertensive drug improves multiple sclerosis-related brain inflammation - Jul 29, 2010
- Why hypertensive people's BP increases during exercise - Apr 05, 2011
- Device lowers BP in patients with difficult-to-treat hypertension - Apr 06, 2011
- Powerful molecule regulator in blood pressure control system discovered - Mar 12, 2010
- Singing lowers patient's BP prior to surgery - Mar 31, 2011
- Combination ACE inhibitor therapy raises risk of kidney failure, death - Mar 22, 2011
- Dopamine also vital for kidney health, lifespan - Jul 20, 2011
- Mechanism that causes high blood pressure uncovered - Oct 07, 2010
- Enzyme may help offer new approach to hypertension therapy - Dec 18, 2009
- Researchers come up with improved therapy for hypertension - Dec 30, 2009
- Novel approach offers new insights into causes of pre-eclampsia - Oct 07, 2010
- Heartbeat may offer insight into kidney health - Jul 09, 2010
- Early life stress could be risk factor for cardiovascular disease - Feb 10, 2010
- BP drugs could protect against dementia - Jul 23, 2009
- Brain chemical that regulates mood may have anti-diabetic properties - Nov 14, 2010
Tags: baroreceptor reflex, blood pressure regulation, brain stem cells, cardiovascular diseases, central nervous system, chronic hypertension, critical functions, critical role, dr eric, high blood pressure, hypertensive hormone, louisiana state university, prevention of hypertension, reflex function, therapeutic target, transgenic mouse model, treatment of high blood pressure, treatment of hypertension, vascular resistance, xia
